262279-88-9 Usage
Description
(1R,4R,6S,7R)-7-bromo-6-hydroxy-2-benzyl-2-azabicyclo[2.2.1]heptan-3-one is a complex bicyclic compound that features a bromine atom, a hydroxyl group, and a benzyl group. Its unique molecular structure, characterized by two fused rings, positions it as a promising candidate for various applications, particularly in the field of medicinal chemistry.
Uses
Used in Medicinal Chemistry:
(1R,4R,6S,7R)-7-bromo-6-hydroxy-2-benzyl-2-azabicyclo[2.2.1]heptan-3-one is used as a pharmaceutical agent for its potential therapeutic properties. Compounds with similar structures have been studied for their medicinal applications, suggesting that this particular compound may also possess beneficial biological activities.
Used in Synthetic and Mechanistic Studies:
Due to the presence of a bromine atom, (1R,4R,6S,7R)-7-bromo-6-hydroxy-2-benzyl-2-azabicyclo[2.2.1]heptan-3-one is used as a subject of synthetic and mechanistic studies. Its chemical reactivity may provide insights into new reaction pathways and contribute to the development of novel synthetic methods.
Used in Chemical Research:
(1R,4R,6S,7R)-7-bromo-6-hydroxy-2-benzyl-2-azabicyclo[2.2.1]heptan-3-one is utilized in chemical research to explore its unique structure and functional groups. Further investigation into this compound could lead to the discovery of new applications and a deeper understanding of its properties in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 262279-88-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,2,2,7 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 262279-88:
(8*2)+(7*6)+(6*2)+(5*2)+(4*7)+(3*9)+(2*8)+(1*8)=159
159 % 10 = 9
So 262279-88-9 is a valid CAS Registry Number.
262279-88-9Relevant articles and documents
A new class of conformationally rigid analogues of 4-amino-5- halopentanoic acids, potent inactivators of γ-aminobutyric acid aminotransferase
Qiu, Jian,Silverman, Richard B.
, p. 706 - 720 (2007/10/03)
Recently, we found (Qiu, J.; Pingsterhaus, J. M.; Silverman, R. B. J. Med. Chem. 1999, 42, 4725-4728) that conformationally rigid analogues of the GABA aminotransferase (GABA-AT) inactivator vigabatrin were not inactivators of GABA-AT. To determine if thi
